CHINA PHARMA HOLDINGS, INC. Inventory, Gross
CHINA PHARMA HOLDINGS, INC. (CPHI) had Inventory, Gross of $2.52 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Inventory, Net › Inventory, Gross
us-gaap:InventoryGross · last filed 2026-08-14
- 2026-06-30: Inventory, Gross $2.52M.
- 2026-03-31: Inventory, Gross $2.62M.
- 2025-12-31: Inventory, Gross $2.77M.
- 2025-09-30: Inventory, Gross $2.74M.
| Period end | Inventory, Gross | Inventory, Gross as first filed |
|---|---|---|
| 2026-06-30 | $2.52M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $2.62M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $2.77M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $2.74M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.68M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.77M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $2.84M 10-K · filed 2026-04-01 | |
| 2023-12-31 | $3.86M 10-K · filed 2025-03-31 | |
| 2017-12-31 | $6.41M 10-K · filed 2018-04-02 | |
| 2017-09-30 | $13.03M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $13.23M 10-Q · filed 2017-08-14 | |
| 2016-12-31 | $7.31M 10-K · filed 2018-04-02 | $13.45M 10-K · filed 2017-03-31 |
| 2016-09-30 | $15.25M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $15.57M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $16.61M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $18.08M 10-K · filed 2017-03-31 | |
| 2014-12-31 | $22.26M 10-K · filed 2016-03-30 | |
| 2013-06-30 | $39.28M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $35.04M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $38.13M 10-Q · filed 2013-08-14 | |
| 2011-12-31 | $30.38M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |